Home
/
OPKO HEALTH, INC.
/
Financials
/
Quarterly
OPKO HEALTH, INC. — Quarterly Financials
Quarterly figures from SEC EDGAR XBRL filings (10-Q)
These figures are extracted from XBRL-tagged quarterly reports (10-Q) that OPKO HEALTH, INC. filed with the SEC. Values are as reported for each individual quarter (Q1, Q2, Q3, Q4) — not cumulative year-to-date. Negative figures indicate a loss.
Revenue — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
$151.67M
Oct 29, 2025
Q2
2025
Jun 30, 2025
$156.81M
Jul 31, 2025
Q1
2025
Mar 31, 2025
$149.95M
May 1, 2025
Q3
2025
Sep 30, 2024
$173.63M
Oct 29, 2025
Q2
2025
Jun 30, 2024
$182.19M
Jul 31, 2025
Q1
2025
Mar 31, 2024
$173.69M
May 1, 2025
Q3
2024
Sep 30, 2023
$178.60M
Nov 7, 2024
Q2
2024
Jun 30, 2023
$265.42M
Aug 7, 2024
Q1
2024
Mar 31, 2023
$237.58M
May 7, 2024
Q3
2023
Sep 30, 2022
$179.74M
Nov 6, 2023
Q2
2023
Jun 30, 2022
$309.89M
Aug 3, 2023
Q1
2023
Mar 31, 2022
$329.22M
May 3, 2023
Q3
2022
Sep 30, 2021
$385.81M
Nov 8, 2022
Q2
2022
Jun 30, 2021
$442.41M
Aug 4, 2022
Q1
2022
Mar 31, 2021
$545.17M
May 9, 2022
Q3
2021
Sep 30, 2020
$428.06M
Oct 28, 2021
Q2
2021
Jun 30, 2020
$301.21M
Jul 29, 2021
Q1
2021
Mar 31, 2020
$211.47M
Apr 28, 2021
Q3
2020
Sep 30, 2019
$228.77M
Oct 29, 2020
Q2
2020
Jun 30, 2019
$226.37M
Jul 31, 2020
Revenue (Net Sales) — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q1
2018
Mar 31, 2018
$254.91M
May 8, 2018
Q3
2017
Sep 30, 2017
$263.50M
Nov 8, 2017
Q2
2017
Jun 30, 2017
$314.21M
Aug 8, 2017
Q1
2018
Mar 31, 2017
$266.38M
May 8, 2018
Q3
2017
Sep 30, 2016
$298.04M
Nov 8, 2017
Q2
2017
Jun 30, 2016
$357.10M
Aug 8, 2017
Q1
2017
Mar 31, 2016
$291.04M
May 10, 2017
Q3
2016
Sep 30, 2015
$143.03M
Nov 7, 2016
Q2
2016
Jun 30, 2015
$42.43M
Aug 8, 2016
Q1
2016
Mar 31, 2015
$30.08M
May 9, 2016
Q3
2015
Sep 30, 2014
$19.77M
Nov 9, 2015
Q2
2015
Jun 30, 2014
$23.55M
Aug 5, 2015
Q1
2015
Mar 31, 2014
$22.27M
May 11, 2015
Q3
2014
Sep 30, 2013
$20.64M
Nov 7, 2014
Q2
2014
Jun 30, 2013
$23.82M
Aug 11, 2014
Q1
2014
Mar 31, 2013
$31.38M
May 9, 2014
Q3
2013
Sep 30, 2012
$11.80M
Nov 12, 2013
Q2
2013
Jun 30, 2012
$10.21M
Aug 9, 2013
Q1
2013
Mar 31, 2012
$8.78M
May 10, 2013
Q3
2012
Sep 30, 2011
$6.81M
Nov 9, 2012
Net Income — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
$21.63M
Oct 29, 2025
Q2
2025
Jun 30, 2025
($148.44M)
Jul 31, 2025
Q1
2025
Mar 31, 2025
($67.61M)
May 1, 2025
Q3
2025
Sep 30, 2024
$24.89M
Oct 29, 2025
Q2
2025
Jun 30, 2024
($10.31M)
Jul 31, 2025
Q1
2025
Mar 31, 2024
($81.84M)
May 1, 2025
Q3
2024
Sep 30, 2023
($84.47M)
Nov 7, 2024
Q2
2024
Jun 30, 2023
($19.64M)
Aug 7, 2024
Q1
2024
Mar 31, 2023
($18.27M)
May 7, 2024
Q3
2023
Sep 30, 2022
($86.09M)
Nov 6, 2023
Q2
2023
Jun 30, 2022
($101.65M)
Aug 3, 2023
Q1
2023
Mar 31, 2022
($55.43M)
May 3, 2023
Q3
2022
Sep 30, 2021
$28.74M
Nov 8, 2022
Q2
2022
Jun 30, 2021
($16.19M)
Aug 4, 2022
Q1
2022
Mar 31, 2021
$31.08M
May 9, 2022
Q3
2021
Sep 30, 2020
$23.72M
Oct 28, 2021
Q2
2021
Jun 30, 2020
$33.70M
Jul 29, 2021
Q1
2021
Mar 31, 2020
($59.13M)
Apr 28, 2021
Q3
2020
Sep 30, 2019
($62.01M)
Oct 29, 2020
Q2
2020
Jun 30, 2019
($59.81M)
Jul 31, 2020
Operating Income — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
$48.06M
Oct 29, 2025
Q2
2025
Jun 30, 2025
($59.98M)
Jul 31, 2025
Q1
2025
Mar 31, 2025
($67.17M)
May 1, 2025
Q3
2025
Sep 30, 2024
$14.22M
Oct 29, 2025
Q2
2025
Jun 30, 2024
($61.67M)
Jul 31, 2025
Q1
2025
Mar 31, 2024
($71.47M)
May 1, 2025
Q3
2024
Sep 30, 2023
($64.41M)
Nov 7, 2024
Q2
2024
Jun 30, 2023
$7.03M
Aug 7, 2024
Q1
2024
Mar 31, 2023
($30.59M)
May 7, 2024
Q3
2023
Sep 30, 2022
($87.82M)
Nov 6, 2023
Q2
2023
Jun 30, 2022
($10.74M)
Aug 3, 2023
Q1
2023
Mar 31, 2022
($72.42M)
May 3, 2023
Q3
2022
Sep 30, 2021
$37.83M
Nov 8, 2022
Q2
2022
Jun 30, 2021
$5.57M
Aug 4, 2022
Q1
2022
Mar 31, 2021
$38.44M
May 9, 2022
Q3
2021
Sep 30, 2020
$21.94M
Oct 28, 2021
Q2
2021
Jun 30, 2020
$27.18M
Jul 29, 2021
Q1
2021
Mar 31, 2020
($40.76M)
Apr 28, 2021
Q3
2020
Sep 30, 2019
($39.01M)
Oct 29, 2020
Q2
2020
Jun 30, 2019
($47.26M)
Jul 31, 2020